Revance Therapeutics EPS Estimates for Current Quarter Analysis

Revance Therapeutics Inc (RVNC)

3.075 0.00 (0.00%) USD | NASDAQ | Dec 26, 15:01

View EPS Estimates for Current Quarter for RVNC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Estimates for Current Quarter Chart

Start Trial

View Historical Data

Start Trial

View Earnings Per Share Estimates Definition

Start Trial

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

View EPS Estimates for Current Quarter Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Estimates for Current Quarter Benchmarks

Start Trial

Recursion Pharmaceuticals Inc	Upgrade
Regeneron Pharmaceuticals Inc	Upgrade
Ligand Pharmaceuticals Inc	Upgrade
MEI Pharma Inc	Upgrade
Cellectar Biosciences Inc	Upgrade

Revenue Estimates for Current Quarter	Upgrade
Revenue Estimates for Next Quarter	Upgrade
Revenue Estimates for Current Fiscal Year	Upgrade
Revenue Estimates for Next Fiscal Year	Upgrade
EPS Estimates for Next Quarter	Upgrade
EPS Estimates for Current Fiscal Year	Upgrade
EPS Estimates for Next Fiscal Year	Upgrade